These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 27492448)

  • 1. Caffeine discontinuation improves acute migraine treatment: a prospective clinic-based study.
    Lee MJ; Choi HA; Choi H; Chung CS
    J Headache Pain; 2016 Dec; 17(1):71. PubMed ID: 27492448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying patients who require a change in their current acute migraine treatment: the Migraine Assessment of Current Therapy (Migraine-ACT) questionnaire.
    Dowson AJ; Tepper SJ; Baos V; Baudet F; D'Amico D; Kilminster S
    Curr Med Res Opin; 2004 Jul; 20(7):1125-35. PubMed ID: 15265257
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of caffeine and caffeine cessation on cerebrovascular reactivity in patients with migraine.
    Gil YE; Lee MJ; Cho S; Chung CS
    Headache; 2022 Feb; 62(2):169-175. PubMed ID: 35114026
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Ambiguous Role of Caffeine in Migraine Headache: From Trigger to Treatment.
    Nowaczewska M; Wiciński M; Kaźmierczak W
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32731623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine abstinence: an ineffective and potentially distressing tinnitus therapy.
    Claire LS; Stothart G; McKenna L; Rogers PJ
    Int J Audiol; 2010 Jan; 49(1):24-9. PubMed ID: 20053154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Predicting Inadequate Response to Acute Migraine Medication: Results From the American Migraine Prevalence and Prevention (AMPP) Study.
    Lipton RB; Munjal S; Buse DC; Fanning KM; Bennett A; Reed ML
    Headache; 2016 Nov; 56(10):1635-1648. PubMed ID: 27731896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Weekend attacks in migraine patients: caused by caffeine withdrawal?
    Couturier EG; Hering R; Steiner TJ
    Cephalalgia; 1992 Apr; 12(2):99-100. PubMed ID: 1576651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allodynia Is Associated With Initial and Sustained Response to Acute Migraine Treatment: Results from the American Migraine Prevalence and Prevention Study.
    Lipton RB; Munjal S; Buse DC; Bennett A; Fanning KM; Burstein R; Reed ML
    Headache; 2017 Jul; 57(7):1026-1040. PubMed ID: 28603893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transformed migraine and medication overuse in a tertiary headache centre--clinical characteristics and treatment outcomes.
    Bigal ME; Rapoport AM; Sheftell FD; Tepper SJ; Lipton RB
    Cephalalgia; 2004 Jun; 24(6):483-90. PubMed ID: 15154858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive and psychomotor performance, mood, and pressor effects of caffeine after 4, 6 and 8 h caffeine abstinence.
    Heatherley SV; Hayward RC; Seers HE; Rogers PJ
    Psychopharmacology (Berl); 2005 Apr; 178(4):461-70. PubMed ID: 15696321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Pain Catastrophizing in Women With Migraine and Obesity.
    Bond DS; Buse DC; Lipton RB; Thomas JG; Rathier L; Roth J; Pavlovic JM; Evans EW; Wing RR
    Headache; 2015; 55(7):923-33. PubMed ID: 26087348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of the caffeine withdrawal symptom questionnaire: caffeine withdrawal symptoms cluster into 7 factors.
    Juliano LM; Huntley ED; Harrell PT; Westerman AT
    Drug Alcohol Depend; 2012 Aug; 124(3):229-34. PubMed ID: 22341956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Rates and reasons for discontinuation of triptans and opioids in episodic migraine: results from the American Migraine Prevalence and Prevention (AMPP) study.
    Holland S; Fanning KM; Serrano D; Buse DC; Reed ML; Lipton RB
    J Neurol Sci; 2013 Mar; 326(1-2):10-7. PubMed ID: 23394974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective Cohort Study of Caffeinated Beverage Intake as a Potential Trigger of Headaches among Migraineurs.
    Mostofsky E; Mittleman MA; Buettner C; Li W; Bertisch SM
    Am J Med; 2019 Aug; 132(8):984-991. PubMed ID: 31402050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Headache impact of chronic and episodic migraine: results from the American Migraine Prevalence and Prevention study.
    Buse D; Manack A; Serrano D; Reed M; Varon S; Turkel C; Lipton R
    Headache; 2012 Jan; 52(1):3-17. PubMed ID: 22106869
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of adherence to triptans: factors of sustained vs lapsed users.
    Cady RK; Maizels M; Reeves DL; Levinson DM; Evans JK
    Headache; 2009 Mar; 49(3):386-94. PubMed ID: 19220501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of pain intensity and time to administration on responsiveness to almotriptan: results from AXERT 12.5 mg Time Versus Intensity Migraine Study (AIMS).
    Freitag FG; Finlayson G; Rapoport AM; Elkind AH; Diamond ML; Unger JR; Fisher AC; Armstrong RB; Hulihan JF; Greenberg SJ;
    Headache; 2007 Apr; 47(4):519-30. PubMed ID: 17445101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative efficacy and safety of calcium carbasalate plus metoclopramide versus ergotamine tartrate plus caffeine in the treatment of acute migraine attacks.
    Le Jeunne C; Gómez JP; Pradalier A; Titus i Albareda F; Joffroy A; Liaño H; Henry P; Lainez JM; Geraud G
    Eur Neurol; 1999 Jan; 41(1):37-43. PubMed ID: 9885327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Caffeine-induced headache in children and adolescents.
    Hering-Hanit R; Gadoth N
    Cephalalgia; 2003 Jun; 23(5):332-5. PubMed ID: 12780761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 3-month analysis of disability, quality of life, and disease course in patients with migraine.
    Raggi A; Leonardi M; Bussone G; D'Amico D
    Headache; 2013 Feb; 53(2):297-309. PubMed ID: 23094760
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.